Preclinical Oncology CRO | Contract Research Drug Development Company

Crown Bioscience is a Contract Research Organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. Our preclinical and translational services offer biotech and pharmaceutical companies the opportunity to remove the guesswork from their research and development. We are driven by our mission to empower our customers to improve human health across the globe. To do this, we engage the finest scientific talent, uphold the highest quality standards, and relentlessly pursue innovation.

Explore Our Innovative Solutions

Advance Your
ADC

Overcome Drug Resistance

Discover Translational Biomarkers

Progress Your
IO Molecule

Integrate Mouse Clinical Trials

Unlock Deeper Insights With Multi-omics Quality Tissue

Our biobank stands apart with ultra-short ischemia times, ensuring unmatched traceability and reliability. Each sample is enriched with over 300 clinical data points, providing an in-depth view of patient outcomes and follow-ups. Comprehensive datasets, including tumor characteristics, therapy response, and biomarker status, empower researchers to drive meaningful insights. This commitment to high-quality, clinically annotated samples is instrumental in achieving replicable results in oncology research.

Industry-leading Customer Experience

The data presented below represents Q4 2024

845 Studies Completed

This data point indicates the total number of studies in Q2 2024 that the CSAT, Customer Effort, and Customer Expectation scores are measured against.